tiprankstipranks
Trending News
More News >
SELLAS Life Sciences Group (SLS)
NASDAQ:SLS

SELLAS Life Sciences Group (SLS) Stock Statistics & Valuation Metrics

Compare
1,009 Followers

Total Valuation

SELLAS Life Sciences Group has a market cap or net worth of $162.64M. The enterprise value is $135.01M.
Market Cap$162.64M
Enterprise Value$135.01M

Share Statistics

SELLAS Life Sciences Group has 99,777,490 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding99,777,490
Owned by Insiders1.67%
Owned by Institutions8.56%

Financial Efficiency

SELLAS Life Sciences Group’s return on equity (ROE) is -3.26 and return on invested capital (ROIC) is -301.10%.
Return on Equity (ROE)-3.26
Return on Assets (ROA)-1.59
Return on Invested Capital (ROIC)-301.10%
Return on Capital Employed (ROCE)-3.18
Revenue Per Employee0.00
Profits Per Employee-2.06M
Employee Count15
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of SELLAS Life Sciences Group is -20.61. SELLAS Life Sciences Group’s PEG ratio is 0.06.
PE Ratio-20.61
PS Ratio0.00
PB Ratio5.15
Price to Fair Value67.25
Price to FCF-4.82
Price to Operating Cash Flow-4.24
PEG Ratio0.06

Income Statement

In the last 12 months, SELLAS Life Sciences Group had revenue of 0.00 and earned -30.88M in profits. Earnings per share was -0.05.
Revenue0.00
Gross Profit0.00
Operating Income-31.51M
Pretax Income-30.88M
Net Income-30.88M
EBITDA-30.88M
Earnings Per Share (EPS)-0.05

Cash Flow

In the last 12 months, operating cash flow was -33.71M and capital expenditures 0.00, giving a free cash flow of -33.71M billion.
Operating Cash Flow-33.71M
Free Cash Flow-33.71M
Free Cash Flow per Share-0.34

Dividends & Yields

SELLAS Life Sciences Group pays an annual dividend of $7025.8, resulting in a dividend yield of ―
Dividend Per Share$7025.8
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.84
52-Week Price Change14.18%
50-Day Moving Average1.46
200-Day Moving Average1.25
Relative Strength Index (RSI)49.40
Average Volume (3m)2.77M

Important Dates

SELLAS Life Sciences Group upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 13, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateApr 27, 2012

Financial Position

SELLAS Life Sciences Group as a current ratio of 1.72, with Debt / Equity ratio of 3.13%
Current Ratio1.72
Quick Ratio1.72
Debt to Market Cap<0.01
Net Debt to EBITDA0.42
Interest Coverage Ratio0.00

Taxes

In the past 12 months, SELLAS Life Sciences Group has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

SELLAS Life Sciences Group EV to EBITDA ratio is -20.19, with an EV/FCF ratio of -17.61.
EV to Sales0.00
EV to EBITDA-20.19
EV to Free Cash Flow-17.61
EV to Operating Cash Flow-17.61

Balance Sheet

SELLAS Life Sciences Group has $28.50M in cash and marketable securities with $870.00K in debt, giving a net cash position of -$27.63M billion.
Cash & Marketable Securities$28.50M
Total Debt$870.00K
Net Cash-$27.63M
Net Cash Per Share-$0.28
Tangible Book Value Per Share$0.01

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for SELLAS Life Sciences Group is $5.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5.75
Price Target Upside257.14% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast60.51%

Scores

Smart Score8
AI Score43
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis